147 related articles for article (PubMed ID: 24045153)
1. A cancer-associated mutation in atypical protein kinase Cι occurs in a substrate-specific recruitment motif.
Linch M; Sanz-Garcia M; Soriano E; Zhang Y; Riou P; Rosse C; Cameron A; Knowles P; Purkiss A; Kjaer S; McDonald NQ; Parker PJ
Sci Signal; 2013 Sep; 6(293):ra82. PubMed ID: 24045153
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif.
Messerschmidt A; Macieira S; Velarde M; Bädeker M; Benda C; Jestel A; Brandstetter H; Neuefeind T; Blaesse M
J Mol Biol; 2005 Sep; 352(4):918-31. PubMed ID: 16125198
[TBL] [Abstract][Full Text] [Related]
3. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
Linch M; Sanz-Garcia M; Rosse C; Riou P; Peel N; Madsen CD; Sahai E; Downward J; Khwaja A; Dillon C; Roffey J; Cameron AJ; Parker PJ
Carcinogenesis; 2014 Feb; 35(2):396-406. PubMed ID: 24072773
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.
Kjær S; Linch M; Purkiss A; Kostelecky B; Knowles PP; Rosse C; Riou P; Soudy C; Kaye S; Patel B; Soriano E; Murray-Rust J; Barton C; Dillon C; Roffey J; Parker PJ; McDonald NQ
Biochem J; 2013 Apr; 451(2):329-42. PubMed ID: 23418854
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5.
Hirano Y; Yoshinaga S; Ogura K; Yokochi M; Noda Y; Sumimoto H; Inagaki F
J Biol Chem; 2004 Jul; 279(30):31883-90. PubMed ID: 15143057
[TBL] [Abstract][Full Text] [Related]
6. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota /lambda and plays a role in microtubule dynamics in the early secretory pathway.
Tisdale EJ
J Biol Chem; 2002 Feb; 277(5):3334-41. PubMed ID: 11724794
[TBL] [Abstract][Full Text] [Related]
7. Substrate recognition mechanism of atypical protein kinase Cs revealed by the structure of PKCι in complex with a substrate peptide from Par-3.
Wang C; Shang Y; Yu J; Zhang M
Structure; 2012 May; 20(5):791-801. PubMed ID: 22579248
[TBL] [Abstract][Full Text] [Related]
8. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
9. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota.
Erdogan E; Lamark T; Stallings-Mann M; Lee Jamieson ; Pellecchia M; Thompson EA; Johansen T; Fields AP
J Biol Chem; 2006 Sep; 281(38):28450-9. PubMed ID: 16861740
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the human full-length protein kinase Ciota.
Macek B; Benda C; Jestel A; Maskos K; Mann M; Messerschmidt A
J Proteome Res; 2008 Jul; 7(7):2928-35. PubMed ID: 18489133
[TBL] [Abstract][Full Text] [Related]
11. Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.
Wald FA; Oriolo AS; Mashukova A; Fregien NL; Langshaw AH; Salas PJ
J Cell Sci; 2008 Mar; 121(Pt 5):644-54. PubMed ID: 18270268
[TBL] [Abstract][Full Text] [Related]
12. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
Regala RP; Weems C; Jamieson L; Copland JA; Thompson EA; Fields AP
J Biol Chem; 2005 Sep; 280(35):31109-15. PubMed ID: 15994303
[TBL] [Abstract][Full Text] [Related]
13. Rab2 interacts directly with atypical protein kinase C (aPKC) iota/lambda and inhibits aPKCiota/lambda-dependent glyceraldehyde-3-phosphate dehydrogenase phosphorylation.
Tisdale EJ
J Biol Chem; 2003 Dec; 278(52):52524-30. PubMed ID: 14570876
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of atypical PKC isoforms in liver parenchymal cells.
Stross C; Keitel V; Winands E; Häussinger D; Kubitz R
Biol Chem; 2009 Mar; 390(3):235-44. PubMed ID: 19090727
[TBL] [Abstract][Full Text] [Related]
15. Coordination of glioblastoma cell motility by PKCι.
Baldwin RM; Barrett GM; Parolin DA; Gillies JK; Paget JA; Lavictoire SJ; Gray DA; Lorimer IA
Mol Cancer; 2010 Sep; 9():233. PubMed ID: 20815904
[TBL] [Abstract][Full Text] [Related]
16. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase.
Jin Z; Xin M; Deng X
J Biol Chem; 2005 Apr; 280(16):16045-52. PubMed ID: 15705582
[TBL] [Abstract][Full Text] [Related]
17. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
18. Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.
Rehmani H; Li Y; Li T; Padia R; Calbay O; Jin L; Chen H; Huang S
Signal Transduct Target Ther; 2020 Aug; 5(1):140. PubMed ID: 32820156
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of atypical protein kinase Cι induces apoptosis through autophagic degradation of β-catenin in esophageal cancer cells.
Wang BS; Yang Y; Lu HZ; Shang L; Zhang Y; Hao JJ; Shi ZZ; Wang XM; Liu YZ; Zhan QM; Jia XM; Wang MR
Mol Carcinog; 2014 Jul; 53(7):514-25. PubMed ID: 23359356
[TBL] [Abstract][Full Text] [Related]
20. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42.
Joberty G; Petersen C; Gao L; Macara IG
Nat Cell Biol; 2000 Aug; 2(8):531-9. PubMed ID: 10934474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
